CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy for rare heart condition put on hold before it began
Disease control TerminatedThis study was designed to test a new gene therapy called ASP2016 for heart problems in people with Friedreich Ataxia, a rare genetic disease. The goal was to check safety and how well people tolerated the treatment, which involved a single infusion plus steroids to protect the t…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Weight loss drug could ease heart failure in obese patients
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether aggressive weight loss using semaglutide can improve symptoms in people with obesity-related heart failure with preserved ejection fraction (HFpEF). About 81 participants will receive either semaglutide or a placebo, and researchers will measure heart pre…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 19, 2026 11:46 UTC
-
World's largest heart rhythm ablation registry launches
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects data from 10,000 people worldwide who are having a procedure called catheter ablation for fast or irregular heartbeats (ventricular tachycardia or PVCs). The goal is to track how well the procedure works and any complications over time. No new treatment is bei…
Matched conditions: CARDIOMYOPATHY
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 26, 2026 05:54 UTC